Literature DB >> 12654182

[Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma].

Yan-Ming Zhou1, Yu-Min Li, Nong Cao, Ying Feng, Feng Zeng.   

Abstract

BACKGROUND &
OBJECTIVE: Epidermal growth factor(EGF) and its receptor(EGFR) play an important role in tumorigenesis. Cholelithiasis and cholecystitis were closely related to gallbladder carcinoma. This study was designed to investigate the relationship between the expression of EGF and EGFR in chronic cholecystitis and gallbladder carcinoma.
METHOD: SABC immunohistochemistry was used to determine the expression of EGF, EGFR, and proliferating cell nuclear antigen (PCNA) in surgically resected specimens of 41 gallbladder carcinomas, 26 simple hyperplasia tissues, 14 dysplasia tissues,and 10 normal gallbladder tissues.
RESULTS: The positive expression rates of EGF and EGFR were higher in gallbladder carcinomas(63.4%,70.7%) and dysplasia tissues (71.4%,85.7%) than in simple hyperplasia tissues (15.4%,27%) and normal gallbladder tissues (0%,0%)(P< 0.01); PCNA counting score tended to increase with the severity of mucosa change degree(P< 0.01), which were 1.0 in normal tissues, 1.0 in simple hyperplasia tissues, 1.9288+/-0.9972 in dysplasia tissues,and 3.0488+/-0.669 in gallbladder carcinomas. Significantly positive correlation were shown between EGF,EGFR, and PCNA(P< 0.05). There was no correlation between EGF, EFGR, and PCNA expression and tumor TNM stage(P>0.05).
CONCLUSION: Expression of EGF and EGFR is involved in the gallbladder carcinogenesis, and is related to high activity of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654182

Source DB:  PubMed          Journal:  Ai Zheng


  6 in total

Review 1.  Pathology of gallbladder carcinoma: current understanding and new perspectives.

Authors:  Munita Meenu Bal; Mukta Ramadwar; Kedar Deodhar; Shailesh Shrikhande
Journal:  Pathol Oncol Res       Date:  2015-01-25       Impact factor: 3.201

2.  Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC).

Authors:  Chhanda Das; Madhumita Mukhopadhyay; Srijana Subba; Ashis Kumar Saha; Biswanath Mukhopadhyay
Journal:  J Lab Physicians       Date:  2021-05-19

3.  Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.

Authors:  Qinglong Li; Zhulin Yang
Journal:  J Exp Clin Cancer Res       Date:  2009-05-18

4.  EGFR expression in gallbladder carcinoma in North America.

Authors:  Matthew Kaufman; Bhoomi Mehrotra; Sewanti Limaye; Sherrie White; Alexander Fuchs; Yehuda Lebowicz; Sandy Nissel-Horowitz; Adrienne Thomas
Journal:  Int J Med Sci       Date:  2008-09-22       Impact factor: 3.738

Review 5.  Targeted Therapy in Biliary Tract Cancers.

Authors:  Amartej Merla; Kenneth G Liu; Lakshmi Rajdev
Journal:  Curr Treat Options Oncol       Date:  2015-10

6.  Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma.

Authors:  Guanghua Yang; Baobing Yin
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.